health ๐ฌ New cancer treatment might skip major surgery
New research shows that chemoradiotherapy is a viable alternative to radical surgery for early-stage rectal cancer. This international trial involved over 500 patients from the UK, Netherlands, Denmark, Belgium, and Sweden. After 12 months, four in five patients treated with chemoradiotherapy kept their rectum. The surgery-free survival was 78.5% for the chemo group versus 60.6% for the radiotherapy-only group. Researchers will now monitor patients for three more years to check long-term outcomes.